Celestica Audit Committee Chair Laurette T. Koellner resigns from Board effective Jan 31, 2025

CELESTICA INC

Laurette T. Koellner will resign as Chair of the Audit Committee and Board member effective January 31, 2025.
Resignation is for personal reasons; no disagreement with Celestica on any matter of operations, policies, or practices.
Celestica has initiated a search for a new director meeting board skill requirements and Diversity Policy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Laurette T. Koellner

Chair of the Audit Committee of the Board of Directors

CLS · CELESTICA INC

Effective: 2025-01-31
Filed: January 22, 2025, 6:59 PM ET

On January 21, 2025, Laurette T. Koellner, Chair of the Audit Committee of the Board of Directors (the "Board") of Celestica Inc. (the "Company"), informed the Company that she will resign as Chair of the Audit Committee and a member of the Board, effective as of January 31, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Laurette T. Koellner resigned as Chair of the Audit Committee of the Board of Directors at CELESTICA INC.

Action: resigned
Role: Chair of the Audit Committee of the Board of Directors

Exact text from the filing

On January 21, 2025, Laurette T. Koellner, Chair of the Audit Committee of the Board of Directors (the "Board") of Celestica Inc. (the "Company"), informed the Company that she will resign as Chair of the Audit Committee and a member of the Board, effective as of January 31, 2025.

View on SEC.gov

CELESTICA INC filing history →

Source: SEC EDGAR

accession 0001104659-25-005070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.